Anaemia in patients with cardiogenic shock complicating acute myocardial infarction: Surrogate marker of poor outcome or therapeutic target?

Eur J Heart Fail. 2024 Feb;26(2):458-459. doi: 10.1002/ejhf.3135. Epub 2024 Jan 21.

Authors

J J Coughlan¹, Xavier Rossello^{2

3

4

5}

Affiliations

¹ Cardiovascular Research Institute, Mater Private Network, Dublin, Ireland.
² Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
³ Cardiology Department, Hospital Universitari Son Espases, Palma, Spain.
⁴ Faculty of Medicine, Universitat de les Illes Balears (UIB), Palma, Spain.
⁵ Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

PMID: 38247170
DOI: 10.1002/ejhf.3135

No abstract available

Publication types

Editorial

MeSH terms

Anemia* / etiology
Biomarkers
Heart Failure* / complications
Humans
Myocardial Infarction* / complications
Myocardial Infarction* / therapy
Shock, Cardiogenic / complications
Shock, Cardiogenic / therapy
Treatment Outcome

Substances

Biomarkers